Skip to content

An unpopular vaccine study produces surprising result

Vaccine reduces risk of HIV infection by one-third in large trial

Inflammation signals heart disease risk in people with HIV

South Africa: Budgeting failures threaten ARV programme

Deaths in older children, teenagers with HIV set to grow in southern Africa

GS-9350 boosts atazanavir just as well as ritonavir

Tobacco, marijuana and alcohol may lower levels of some anti-HIV drugs

Dual maintenance therapy with atazanavir plus raltegravir sustains viral suppression

Once-daily Kaletra approved in the European Union